201 related articles for article (PubMed ID: 25747271)
1. 25I-NBOMe related death in Australia: a case report.
Kueppers VB; Cooke CT
Forensic Sci Int; 2015 Apr; 249():e15-8. PubMed ID: 25747271
[TBL] [Abstract][Full Text] [Related]
2. Retrospective Demonstration of 25I-NBOMe Acute Poisoning Using Hair Analysis.
Ameline A; Farrugia A; Raul JS; Kintz P
Curr Pharm Biotechnol; 2017; 18(10):786-790. PubMed ID: 29189143
[TBL] [Abstract][Full Text] [Related]
3. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review.
Kamińska K; Świt P; Malek K
J Anal Toxicol; 2021 Jan; 44(9):947-956. PubMed ID: 32128596
[TBL] [Abstract][Full Text] [Related]
4. Evolution of the NBOMes: 25C- and 25B- Sold as 25I-NBOMe.
Laskowski LK; Elbakoush F; Calvo J; Exantus-Bernard G; Fong J; Poklis JL; Poklis A; Nelson LS
J Med Toxicol; 2015 Jun; 11(2):237-41. PubMed ID: 25387562
[TBL] [Abstract][Full Text] [Related]
5. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing.
Stellpflug SJ; Kealey SE; Hegarty CB; Janis GC
J Med Toxicol; 2014 Mar; 10(1):45-50. PubMed ID: 23872917
[TBL] [Abstract][Full Text] [Related]
6. Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus.
Hermanns-Clausen M; Angerer V; Kithinji J; Grumann C; Auwärter V
Clin Toxicol (Phila); 2017 Sep; 55(8):922-924. PubMed ID: 28471280
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
Wood DM; Sedefov R; Cunningham A; Dargan PI
Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
[TBL] [Abstract][Full Text] [Related]
8. Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication.
Poklis JL; Dempsey SK; Liu K; Ritter JK; Wolf C; Zhang S; Poklis A
J Anal Toxicol; 2015 Oct; 39(8):607-16. PubMed ID: 26378134
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH.
Nielsen LM; Holm NB; Leth-Petersen S; Kristensen JL; Olsen L; Linnet K
Drug Test Anal; 2017 May; 9(5):671-679. PubMed ID: 27400739
[TBL] [Abstract][Full Text] [Related]
10. NBOMe designer drug exposures reported to Texas poison centers.
Forrester MB
J Addict Dis; 2014; 33(3):196-201. PubMed ID: 25115175
[TBL] [Abstract][Full Text] [Related]
11. 25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes, in vivo mouse and human urine with high-resolution mass spectrometry.
Wohlfarth A; Roman M; Andersson M; Kugelberg FC; Diao X; Carlier J; Eriksson C; Wu X; Konradsson P; Josefsson M; Huestis MA; Kronstrand R
Drug Test Anal; 2017 May; 9(5):680-698. PubMed ID: 27448631
[TBL] [Abstract][Full Text] [Related]
12. Fatal Intoxications with 25B-NBOMe and 25I-NBOMe in Indiana During 2014.
Shanks KG; Sozio T; Behonick GS
J Anal Toxicol; 2015 Oct; 39(8):602-6. PubMed ID: 26378133
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of the "Neverending Trip" after administration of a potent full agonist of 5-HT2A receptor - 25I-NBOMe.
Schetz D; Schetz A; Kocić I
Biomed Pharmacother; 2022 Feb; 146():112295. PubMed ID: 34980551
[TBL] [Abstract][Full Text] [Related]
14. Pathological findings in 2 cases of fatal 25I-NBOMe toxicity.
Walterscheid JP; Phillips GT; Lopez AE; Gonsoulin ML; Chen HH; Sanchez LA
Am J Forensic Med Pathol; 2014 Mar; 35(1):20-5. PubMed ID: 24457586
[TBL] [Abstract][Full Text] [Related]
15. Studies on the metabolism and toxicological detection of the new psychoactive designer drug 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe) in human and rat urine using GC-MS, LC-MS(n), and LC-HR-MS/MS.
Caspar AT; Helfer AG; Michely JA; Auwärter V; Brandt SD; Meyer MR; Maurer HH
Anal Bioanal Chem; 2015 Sep; 407(22):6697-719. PubMed ID: 26108532
[TBL] [Abstract][Full Text] [Related]
16. A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State.
Lowe LM; Peterson BL; Couper FJ
J Anal Toxicol; 2015 Oct; 39(8):668-71. PubMed ID: 26378143
[TBL] [Abstract][Full Text] [Related]
17. "My friend said it was good LSD": a suicide attempt following analytically confirmed 25I-NBOMe ingestion.
Suzuki J; Poklis JL; Poklis A
J Psychoactive Drugs; 2014; 46(5):379-82. PubMed ID: 25364988
[TBL] [Abstract][Full Text] [Related]
18. The electric Kool-Aid NBOMe test: LC-TOF/MS confirmed 2C-C-NBOMe (25C) intoxication at Burning Man.
Armenian P; Gerona RR
Am J Emerg Med; 2014 Nov; 32(11):1444.e3-5. PubMed ID: 24908444
[TBL] [Abstract][Full Text] [Related]
19. Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases.
Gee P; Schep LJ; Jensen BP; Moore G; Barrington S
Clin Toxicol (Phila); 2016; 54(2):141-6. PubMed ID: 26621342
[TBL] [Abstract][Full Text] [Related]
20. Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats.
Herian M; Wojtas A; Kamińska K; Świt P; Wach A; Gołembiowska K
Neurotox Res; 2019 Jul; 36(1):91-100. PubMed ID: 30989482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
